Covestor’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-243
Closed -$25K 2410
2025
Q4
$25K Sell
243
-31
-11% -$2.49K 0.01% 1181
2025
Q3
$15K Buy
274
+35
+15% +$1.75K 0.01% 1391
2025
Q2
$13K Sell
239
-50
-17% -$2.54K 0.01% 1402
2025
Q1
$13K Sell
289
-483
-63% -$24.5K 0.01% 1343
2024
Q4
$43K Sell
772
-162
-17% -$10.1K 0.03% 911
2024
Q3
$64K Sell
934
-180
-16% -$10.2K 0.04% 766
2024
Q2
$47K Sell
1,114
-305
-21% -$16.8K 0.03% 883
2024
Q1
$98K Buy
1,419
+615
+76% +$38.9K 0.06% 547
2023
Q4
$60K Buy
804
+665
+478% +$43.6K 0.04% 764
2023
Q3
$10K Sell
139
-74
-35% -$6.28K 0.01% 1420
2023
Q2
$20K Sell
213
-2
-0.9% -$156 0.02% 1132
2023
Q1
$15K Buy
215
+17
+9% +$1.09K 0.01% 1108
2022
Q4
$10K Hold
198
0.01% 1320
2022
Q3
$6K Buy
198
+72
+57% +$2.97K 0.01% 1439
2022
Q2
$5K Sell
126
-7
-5% -$374 ﹤0.01% 1400
2022
Q1
$9K Buy
133
+52
+64% +$3.8K 0.01% 1344
2021
Q4
$6K Buy
+81
New +$7.15K 0.01% 1219

Other funds holding EXAS

Covestor's EXAS Position: Q1 2026 in Review

Covestor sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 243 shares — an estimated $25K sold.

Covestor first reported a position in EXAS in Q4 2021 and held it in 17 quarters. The position peaked at $98K in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Covestor reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 243 Exact Sciences shares in Q1 2026, an estimated $25K.
  • Covestor first reported a position in Exact Sciences in Q4 2021 and held it in 17 quarters.
  • Covestor's Exact Sciences position peaked at $98K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.